JENNIFER SMITH: Open Payments
NPI 1134548654 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 100 payments from 11 companies in 2025. Trend: 2023 $1,781 · 2024 $1,540 · 2025 $1,857
Food & beverage: $1,812Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $547 |
| Novartis Pharmaceuticals Corporation | 22 | $327 |
| GlaxoSmithKline, LLC. | 11 | $296 |
| Amgen Inc. | 14 | $212 |
| Janssen Biotech, Inc. | 8 | $141 |
| UCB, Inc. | 8 | $137 |
| GENZYME CORPORATION | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| TerSera Therapeutics LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: RINVOQ, COSENTYX, BENLYSTA, SKYRIZI, TREMFYA, OTEZLA, Bimzelx, KEVZARA.
Industry payments across AL — which companies pay providers there.
